| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 17-Feb-26 | Sell | Stuart Machin | 404.00p | 150,000 | £605,999.99 |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 17-Feb-26 | Sell | Stuart Machin | 404.00p | 150,000 | £605,999.99 |
| Notifier | Holding | Value* |
|---|---|---|
| Stuart Machin | 6,371,299 | £25,720,934 |
| Archie Norman | 148,600 | £599,898 |
| Alison Dolan | 124,619 | £503,087 |
| Cheryl Potter | 50,000 | £201,850 |
| Evelyn Bourke | 50,000 | £201,850 |
| Fiona Dawson | 28,004 | £113,052 |
| Sean Doyle | 5,052 | £20,395 |
| Sapna Sood | 2,000 | £8,074 |
| Tamara Ingram | 2,000 | £8,074 |
| Notifier** | Holding | Value* |
|---|---|---|
| BlackRock Inc | 115,786,542 | £467,430,270 |
| Ameriprise Financial, Inc | 101,086,559 | £408,086,439 |
| Citadel LLC and its group | 97,679,549 | £394,332,339 |
| RWC Asset Management LLP | 97,433,541 | £393,339,205 |
| Schroders plc | 93,880,279 | £378,994,686 |
| Majedie Asset Management Limited | 81,070,667 | £327,282,283 |
| Norges Bank | 61,903,208 | £249,903,251 |
| Bank of Nova Scotia | 51,235,305 | £206,836,926 |
| The Bank of Nova Scotia | 2,578,006 | £10,407,410 |
| Currency | UK Pounds |
| Share Price | 403.70p |
| Change Today | -3.20p |
| % Change | -0.79 % |
| 52 Week High | 411.30p |
| 52 Week Low | 318.40p |
| Volume | 7,221,531 |
| Shares Issued | 2,057.21m |
| Market Cap | £8,305m |
| Beta | 0.86 |
| RiskGrade | 211 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 5 |
| Neutral | 3 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 16 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 27-Nov-25 | 29-May-25 |
| Paid | 09-Jan-26 | 04-Jul-25 |
| Amount | 1.20p | 2.60p |
| Time | Volume / Share Price |
| 14:47 | 7 @ 405.80p |
| 16:35 | 178,844 @ 403.70p |
| 16:35 | 357,688 @ 403.70p |
| 16:35 | 2,985,119 @ 403.70p |
| 16:35 | 2,650 @ 403.70p |
| Chair | Archie Norman |
| CEO | Stuart Machin |
| CFO | Alison Dolan |
You are here: research